Pharmacokinetic optimization of antiretroviral therapy in pregnancy
Antiretroviral therapy suppresses replication of HIV allowing restoration and/or preservation of the immune system. Providing combination antiretroviral therapy during pregnancy can treat maternal HIV infection and/or reduce perinatal HIV transmission. However, providing treatment to pregnant women...
Saved in:
Main Authors: | Buckoreelall K., Cressey T., King J. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84873466060&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42759 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Pharmacokinetic optimization of antiretroviral therapy in pregnancy
by: Kajal Buckoreelall, et al.
Published: (2018) -
Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate Monotherapy
by: Vera E. Bukkems, et al.
Published: (2020) -
The role of formulation on the pharmacokinetics of antiretroviral drugs
by: Diane Et Bastiaans, et al.
Published: (2018) -
The role of formulation on the pharmacokinetics of antiretroviral drugs
by: Diane Et Bastiaans, et al.
Published: (2018) -
Does pregnancy affect the pharmacokinetics of efavirenz?
by: Andrew Hill, et al.
Published: (2018)